We are live on ! Find out more
LCS

Levin Capital Strategies Portfolio holdings

AUM $1.32B
1-Year Est. Return 28.11%
This Fund
S&P 500
This Quarter Est. Return
+3.15%
1 Year Est. Return
+28.11%
3 Year Est. Return
+79.27%
5 Year Est. Return
+107.45%
10 Year Est. Return
+287.53%
AUM
$6.62B
AUM Growth
+$46.9M
Cap. Flow
-$86.3M
Cap. Flow %
-1.3%
Top 10 Hldgs %
36.98%
Holding
455
New
119
Increased
95
Reduced
103
Closed
74

Top Sells

Rank Stock Value
1
HOLX
Hologic
HOLX
+$62.5M
2
DS
Drive Shack Inc.
DS
+$62.2M
3
NOV icon
NOV
NOV
+$60.4M
4
PCG icon
PG&E
PCG
+$48.4M
5
WAT icon
Waters Corp
WAT
+$47.3M

Sector Composition

Rank Sector Weight
1 Financials 17.35%
2 Healthcare 16.64%
3 Technology 14.28%
4 Industrials 12.67%
5 Consumer Staples 9.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PFE icon
1
Pfizer
PFE
$142B
$328M 4.95%
11,092,804
+474,149
+4% +$13.6M
ETN icon
2
Eaton
ETN
$150B
$279M 4.21%
4,103,799
+440,651
+12% +$29.1M
GE icon
3
GE Aerospace
GE
$368B
$273M 4.13%
2,255,068
+157,354
+8% +$19.3M
C icon
4
Citigroup
C
$222B
$261M 3.95%
4,825,291
+301,806
+7% +$16M
PF
5
DELISTED
Pinnacle Foods, Inc.
PF
$249M 3.76%
7,045,888
+536,480
+8% +$18.1M
EMC
6
DELISTED
EMC CORPORATION
EMC
$229M 3.46%
7,702,524
+1,084,354
+16% +$31.6M
JPM icon
7
JPMorgan Chase
JPM
$933B
$228M 3.44%
3,638,599
+60,755
+2% +$3.66M
OXY icon
8
Occidental Petroleum
OXY
$55.6B
$206M 3.11%
2,554,312
+67,498
+3% +$5.6M
CVA
9
DELISTED
Covanta Holding Corporation
CVA
$200M 3.02%
9,092,754
-1,498,655
-14% -$33.7M
ALL icon
10
Allstate
ALL
$68.3B
$195M 2.95%
2,776,149
-184,373
-6% -$12.1M
AAPL icon
11
Apple
AAPL
$4.9T
$153M 2.31%
5,531,584
-1,702,580
-24% -$46.3M
MDT icon
12
Medtronic
MDT
$110B
$138M 2.09%
1,912,959
-462,657
-19% -$32.1M
ORCL icon
13
Oracle
ORCL
$367B
$135M 2.03%
2,993,494
+198,556
+7% +$8.08M
AMAT icon
14
Applied Materials
AMAT
$398B
$132M 2%
5,299,620
+693,153
+15% +$15.7M
AGN
15
DELISTED
Allergan plc
AGN
$131M 1.98%
508,982
-42,406
-8% -$10.6M
GM icon
16
General Motors
GM
$80B
$128M 1.94%
3,676,162
+328,209
+10% +$10.5M
PHG icon
17
Philips
PHG
$25.8B
$123M 1.86%
6,122,329
+1,413,193
+30% +$28.2M
CB icon
18
Chubb
CB
$135B
$122M 1.85%
1,065,260
+19,090
+2% +$2.11M
WMB icon
19
Williams Companies
WMB
$86.7B
$111M 1.68%
2,470,191
+778,376
+46% +$39.8M
BIO icon
20
Bio-Rad Laboratories Class A
BIO
$8.74B
$101M 1.52%
836,727
-196,154
-19% -$22.6M
XLS
21
DELISTED
EXELIS INC COM STK
XLS
$89.8M 1.36%
5,121,678
-136,629
-3% -$2.36M
MET icon
22
MetLife
MET
$62.5B
$85.6M 1.29%
1,774,648
+117,827
+7% +$5.6M
VWR
23
DELISTED
VWR Corporation
VWR
$82.3M 1.24%
+3,182,086
New +$75.9M
PRMW
24
DELISTED
Primo Water Corporation
PRMW
$75.3M 1.14%
10,946,551
+2,259,600
+26% +$14.8M
CAM
25
DELISTED
CAMERON INTERNATIONAL CORPORATION
CAM
$73.1M 1.11%
1,463,998
+389,286
+36% +$21.5M

Similar funds

Levin Capital Strategies's Q4 2014 Portfolio in Review

As of Q4 2014, Levin Capital Strategies held 455 positions worth $6.62B, up 0.71% from $6.57B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Levin Capital Strategies's Q4 2014 filing shows 119 new, 95 increased, 103 reduced and 74 closed positions. Its largest new stake was VWR Corporation: 3,182,086 shares worth $82.3M. The largest sale was Hologic, an estimated $62.5M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Technology.

  • Levin Capital Strategies's largest Q4 2014 buy was VWR Corporation: 3,182,086 shares worth $82.3M.
  • Levin Capital Strategies added most to Anadarko Petroleum in Q4 2014, an estimated $48M increase.
  • Levin Capital Strategies's biggest Q4 2014 reduction was Hologic, cutting an estimated $62.5M.
  • Levin Capital Strategies fully exited PG&E in Q4 2014, selling an estimated $48.4M.
  • Levin Capital Strategies's ten largest holdings make up 37% of its $6.62B portfolio in Q4 2014.
  • Levin Capital Strategies opened 119 new positions and closed 74 in Q4 2014.
  • Levin Capital Strategies's portfolio value rose 0.71% quarter-over-quarter to $6.62B.

Based on Levin Capital Strategies's 13F filing for Q4 2014, filed 12 Feb 2015.